Biotech News

Progyny, Inc. Announces Share Repurchase Program

Progyny (PGNY)ProgynyCompany update

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock.

Related news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States